Neuroproteomics and Metalloproteomics Laboratory
The Neuroproteomics and Metalloproteomics Laboratory focuses on using proteomics to understand Alzheimer’s disease, Parkinson’s disease and amyotrophic lateral sclerosis.
The group has a particular interest in understanding the role of metals in biology and has developed new proteomic technologies to measure metalloproteins. Further, this group is using proteomics to characterize new blood borne biomarkers for Alzheimer’s and Parkinson’s disease.
Brain health affects all Australians. You can support our research by making a donation or a bequest.